Dirk G. Brockstedt, Ph.D.
About Dirk G. Brockstedt, Ph.D.
Dirk Brockstedt Ph.D. - Chief Scientific Officer at RAPT Therapeutics
Dirk Brockstedt, Ph.D., currently serves as the Chief Scientific Officer at RAPT Therapeutics. He joined the company in January 2018, bringing with him over 20 years of experience in discovery, translational, and clinical development. His expertise includes deep knowledge of immunology and the tumor microenvironment.
Dirk Brockstedt's Educational Background
Dirk Brockstedt holds both an M.S. and a Ph.D. from the University of Kiel. During his Ph.D. studies, he engaged in graduate research at Stanford University. Following his doctoral studies, he completed a post-doctoral fellowship at the Stanford School of Medicine in the Department of Pathology.
Dirk Brockstedt's Experience in Immunology
Dirk Brockstedt has extensive experience in the field of immunology. He previously served as the Executive Vice President of Research and Development at Aduro Biotech. Before that, he held increasing leadership positions within the immunology department at Cerus Corporation, ultimately serving as the Director of Immunology. His career includes time at Aventis, where he worked in the immunotherapy and anti-angiogenesis group to develop novel cancer therapies.
Dirk Brockstedt's Scientific Contributions
Dirk Brockstedt has co-authored over 50 scientific papers and is a named inventor on seven issued patents, with several more applications pending. His contributions to the field have been significant, particularly in the areas of immunology and cancer therapy development.